ENLIE Pharmaceutical JSC (HSTC:BCP) Earnings per Share (Diluted) : ₫ (TTM As of . 20)

ENLIE Pharmaceutical JSC Earnings per Share (Diluted) Chart

Competitive Comparison of ENLIE Pharmaceutical JSC's Earnings per Share (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, ENLIE Pharmaceutical JSC's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ENLIE Pharmaceutical JSC's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ENLIE Pharmaceutical JSC's PE Ratio distribution charts can be found below:

* The bar in red indicates where ENLIE Pharmaceutical JSC's PE Ratio falls into.

ENLIE Pharmaceutical JSC Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

ENLIE Pharmaceutical JSC's Earnings Per Share (Diluted) for the fiscal year that ended in . 20 is calculated as

ENLIE Pharmaceutical JSC's Earnings Per Share (Diluted) for the quarter that ended in . 20 is calculated as

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

ENLIE Pharmaceutical JSC  (HSTC:BCP) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

ENLIE Pharmaceutical JSC Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of ENLIE Pharmaceutical JSC's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

ENLIE Pharmaceutical JSC (HSTC:BCP) Business Description